Latest Capital Raising News

Page 89 of 445
Stavely Minerals Limited reported a net cash outflow from operations of AUD 1.264 million for Q3 2025 but bolstered its cash reserves through financing activities, ending the quarter with AUD 1.722 million. The company signals a strategic reduction in exploration expenditure for the upcoming quarter to sustain operations.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Austral Resources Australia Ltd reported robust Q3 2025 copper production and secured $40 million in new capital, setting the stage for accelerated growth and ASX reinstatement.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Mount Hope Mining has raised $2.48 million through a placement and share purchase plan to accelerate drilling at its Mt Solitary gold prospect and the broader 7.5km gold corridor in the prolific Cobar Basin.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Eclipse Metals has advanced its Greenland rare earths project with expanded drilling and a key licence renewal, while preparing for a NASDAQ dual listing to tap North American investors.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Omnia Metals Group has successfully issued 54 million shares, raising $1.08 million as part of a broader $1.58 million placement. The company now looks to shareholders for approval to complete the remaining share and option issues.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.
Ada Torres
Ada Torres
29 Oct 2025
Arafura Rare Earths has successfully raised A$475 million through a two-tranche institutional placement, backed by major investors including Hancock Prospecting, to fund the development of its Nolans Project.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Whitebark Energy’s fresh petrophysical analysis reveals significant dry gas zones in its Warro Gas Field, boosting its commercial prospects and prompting a $750,000 capital raise to fast-track development.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.
Ada Torres
Ada Torres
29 Oct 2025
FIN Resources Limited has executed a binding agreement to acquire the fully permitted, high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, setting the stage for immediate exploration and resource growth.
Maxwell Dee
Maxwell Dee
29 Oct 2025
1414 Degrees has completed key milestones on its SiBox technology, advanced SiBrick storage media towards mass production, and acquired an exclusive licence for innovative silicon nanoparticle tech, backed by a $1.214 million capital raise.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.
Maxwell Dee
Maxwell Dee
29 Oct 2025